APA (7th ed.) Citation

Dattilo, G., Laterra, G., Licordari, R., Parisi, F., Pistelli, L., Colarusso, L., . . . Correale, M. (2023). The Long-Term Benefit of Sacubitril/Valsartan in Patients with HFrEF: A 5-Year Follow-Up Study in a Real World Population. Journal of Clinical Medicine, 12(19), 6247. https://doi.org/10.3390/jcm12196247

Chicago Style (17th ed.) Citation

Dattilo, Giuseppe, et al. "The Long-Term Benefit of Sacubitril/Valsartan in Patients with HFrEF: A 5-Year Follow-Up Study in a Real World Population." Journal of Clinical Medicine 12, no. 19 (2023): 6247. https://doi.org/10.3390/jcm12196247.

MLA (9th ed.) Citation

Dattilo, Giuseppe, et al. "The Long-Term Benefit of Sacubitril/Valsartan in Patients with HFrEF: A 5-Year Follow-Up Study in a Real World Population." Journal of Clinical Medicine, vol. 12, no. 19, 2023, p. 6247, https://doi.org/10.3390/jcm12196247.